- Tongwei expects a preliminary net loss ranging between 7 billion yuan and 7.5 billion yuan for the fiscal year.
- The estimated loss was initially predicted to be 4.97 billion yuan, indicating a higher than expected financial shortfall.
- The company attributes this increased loss primarily to declines in solar product prices in 2024.
- Market analysts have given Tongwei the following ratings: 20 buy recommendations, 5 hold ratings, and 6 sell ratings.
A look at Tongwei Co Ltd A Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 4 | |
| Dividend | 5 | |
| Growth | 2 | |
| Resilience | 2 | |
| Momentum | 3 | |
| OVERALL SMART SCORE | 3.2 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Based on the Smartkarma Smart Scores, Tongwei Co Ltd A shows a positive long-term outlook, with high scores in Value and Dividend factors, indicating a company that is considered undervalued and pays good dividends to its investors. However, the Growth, Resilience, and Momentum scores are lower, suggesting potential areas of improvement in terms of growth prospects, ability to withstand economic fluctuations, and market momentum.
Tongwei Co Ltd A, a company that specializes in producing and selling aquatic and animal feeds, along with animal medicines, is positioned well for the future with solid value and dividend offerings. While there may be room for growth enhancement and increased resilience to market changes, the company’s strengths lie in its ability to provide consistent value and reliable dividend payouts to its stakeholders.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
